Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells. | Cells | 2021 | 34831128 | PubTator, text mining | PubMed |
| What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment. | Int J Mol Sci | 2021 | 34830209 | PubTator, text mining | PubMed |
| EFNB1 Acts as a Novel Prognosis Marker in Glioblastoma through Bioinformatics Methods and Experimental Validation. | J Oncol | 2021 | 34824583 | PubTator, text mining | PubMed |
| Hematopoiesis under telomere attrition at the single-cell resolution. | Nat Commun | 2021 | 34824242 | PubTator, text mining | PubMed |
| High efficiency closed-system gene transfer using automated spinoculation. | J Transl Med | 2021 | 34819105 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets. | Front Oncol | 2021 | 34804946 | PubTator, text mining | PubMed |
| Bioinformatics analyses of the pathogenesis and new biomarkers of chronic obstructive pulmonary disease. | Medicine (Baltimore) | 2021 | 34797299 | PubTator, text mining | PubMed |
| Meta-Analysis of Esophageal Cancer Transcriptomes Using Independent Component Analysis. | Front Genet | 2021 | 34795689 | PubTator, text mining | PubMed |
| Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors. | Nat Commun | 2021 | 34795224 | PubTator, text mining | PubMed |
| Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer. | Dis Markers | 2021 | 34790279 | PubTator, text mining | PubMed |
| Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma. | J Immunother Cancer | 2021 | 34782430 | PubTator, text mining | PubMed |
| NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity. | Blood Cancer Discov | 2021 | 34778803 | PubTator, text mining | PubMed |
| Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies. | Front Immunol | 2021 | 34777383 | PubTator, text mining | PubMed |
| Editorial: Transcriptional Regulation as a Key Player in Cancer Cells Drug Resistance. | Front Oncol | 2021 | 34765559 | PubTator, text mining | PubMed |
| The Transcriptome Characteristics of Severe Asthma From the Prospect of Co-Expressed Gene Modules. | Front Genet | 2021 | 34759961 | PubTator, text mining | PubMed |
| The Clinical Significance and Immunization of MSMO1 in Cervical Squamous Cell Carcinoma Based on Bioinformatics Analysis. | Front Genet | 2021 | 34759952 | PubTator, text mining | PubMed |
| The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas. | iScience | 2021 | 34755091 | PubTator, text mining | PubMed |
| Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies. | Immunotargets Ther | 2021 | 34754837 | PubTator, text mining | PubMed |
| The role of dendritic cells and their interactions in the pathogenesis of antibody-associated autoimmune encephalitis. | J Neuroinflammation | 2021 | 34749759 | PubTator, text mining | PubMed |
| Analysis of evolutionary conservation of GPI-anchored proteins between humans and mice. | Blood Cells Mol Dis | 2021 | 34749066 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=59